
Quadrivio purchases 70% stake in Farmol for €20.5m
Italian private equity house Quadrivio has acquired a 70% stake in cosmetics and detergents manufacturer Farmol for €20.5m.
Quadrivio bought the stake from the owning Innocenti family, which will retain 30%. The GP invested via its third vehicle, Quadrivio Private Equity Fund 3, in a deal understood to value the company at 6x the EBITDA posted in 2015.
According to a statement, the company aims to use the capital to boost its expansion through the opening of a new production plant in Slovakia.
The deal marks the second transaction for the GP's 2015-vintage vehicle, following the acquisition of printed circuit board producer Somacis Group for €100m in February 2016.
Previous funding
In April 2012, government-backed private equity house Fondo Italiano d'Investimento (FII) acquired a minority stake in the business for €11.25m. The investment included a capital injection and a convertible loan.
At the end of 2013, following relevant changes in the company's macroeconomic backdrop, FII sold its stake to the existing shareholders and issued a €3m convertible loan. More recently, FII sold its convertible note for €5.8m in April 2016.
Company
Established in 1946 and headquartered in Bergamo, Farmol manufactures aerosol- and liquid-based products, focusing on cosmetics, detergents and medical-surgical devices.
To date, the company has four manufacturing sites, two in Italy, one in Hungary and one in Tunisia. Farmol reportedly posted a turnover of €69m in 2015, with €5.5m in EBITDA and €2.5m net debt. The business generates 75% of its revenues from exports, it said in a statement.
People
Quadrivio – Alessandro Binello (chair); Walter Ricciotti (CEO).
Farmol – Carlo Innocenti (CEO).
Advisers
Equity – Legance Studio Legale Associato (legal); Schoenherr (legal); EY (commercial due diligence); Studio Russo De Rosa Associati (tax).
Vendor – Deloitte (financial due diligence); Studio Cesare Vecchio (legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater